Literature DB >> 20432391

Biodisk: a new device for closure of patent foramen ovale: a feasibility study in swine.

Dusan Pavcnik1, Kurt Takulve, Barry T Uchida, Maja Pavcnik Arnol, William VanAlstine, Frederick Keller, Josef Rösch.   

Abstract

PURPOSE: To evaluate the feasibility, effectiveness, and safety of a porcine small intestinal submucosa (SIS)-covered Biodisk (BD) for the closure of patent foramen ovale (PFO) in swine.
METHODS: Twelve piglets (9-30 kg) with PFO ranging in size from 6 to 12 mm were used for the in vivo testing. The BD device consisted of two basic nitinol wire components covered with platinum coil, a flexible SIS-covered ring, and an anchor. The BD was advanced through an 8-Fr sheath from the femoral vein. Nine acute animals were used to test the BD for deployment, stability, immediate shunt closure, and device repositioning before or after its detachment. To assess retrievability, four devices were deployed and intentionally embolized into the RA (n = 2) and LA (n = 2). The effectiveness of the device was evaluated by angiocardiography. EKG was recorded before and after PFO closure for 3 hr. From the 12 animals, nine were acute and three were followed; one for 6 weeks, one for 12 weeks, and one for 16 weeks.
RESULTS: Successful device implantation was achieved in all animals with no shunting of contrast media observed during follow-up in. One animal needed to have device repositioned for complete PFO occlusion because of suboptimal placement at the first attempt. The device was easily placed and retrieved before detachment in all nine animals in the acute study. None of the BDs spontaneously embolized during release or on follow-up. EKG did not demonstrate arrhythmias during or after treatment. Four intentionally embolized BDs were easily retrieved with an Amplatz goose neck snare. Macroscopic and histologic evaluation of the three long-term animals showed that devices were well incorporated in the atrial septum with complete shunt closure. The SIS showed progressive remodeling with the host cells. There was also progressive endothelization of the BD device.
CONCLUSION: The BD device deployment is feasible, safe, and effective. Long-term studies are needed to evaluate its long-term effectiveness. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20432391     DOI: 10.1002/ccd.22429

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Infrahepatic caudal/inferior vena cava interruption with azygos/hemiazygos continuation. Vascular anomaly in swine.

Authors:  Miran Jeromel; Dusan Pavcnik
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

2.  Study of biodegradable occluder of atrial septal defect in a porcine model.

Authors:  Bo-Ning Li; Yu-Mei Xie; Zhao-Feng Xie; Xian-Miao Chen; Gui Zhang; De-Yuan Zhang; Xiang-Dong Liu; Zhi-Wei Zhang
Journal:  Catheter Cardiovasc Interv       Date:  2018-09-09       Impact factor: 2.692

Review 3.  The Future of Paediatric Heart Interventions: Where Will We Be in 2030?

Authors:  Tomohito Kogure; Shakeel A Qureshi
Journal:  Curr Cardiol Rep       Date:  2020-10-09       Impact factor: 2.931

4.  Double BioDisk: a new bioprosthetic device for transcatheter closure of atrial septal defects - a feasibility study in adult sheep.

Authors:  Dusan Pavcnik; Kurt Tekulve; Barry T Uchida; Zhong-Huo Luo; Miran Jeromel; William G Van Alstine; Frederick S Keller; Josef Rösch
Journal:  Radiol Oncol       Date:  2012-05-30       Impact factor: 2.991

5.  Initial experiences with a novel biodegradable device for percutaneous closure of atrial septal defects: From preclinical study to first-in-human experience.

Authors:  Yi-Fan Li; Yu-Mei Xie; Jun Chen; Bo-Ning Li; Zhao-Feng Xie; Shu-Shui Wang; Zhi-Wei Zhang
Journal:  Catheter Cardiovasc Interv       Date:  2019-11-12       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.